Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_assertion type Assertion NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_head.
- NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_assertion description "[Functional polymorphisms that predispose to increased basal GRK4 activity both decrease dopamine receptor activity and increase angiotensin II type 1 (AT1) receptor activity and are associated with essential hypertension in a number of different human cohorts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_provenance.
- NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_assertion evidence source_evidence_literature NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_provenance.
- NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_assertion SIO_000772 22407378 NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_provenance.
- NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_assertion wasDerivedFrom befree-20150227 NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_provenance.
- NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_assertion wasGeneratedBy ECO_0000203 NP817280.RAF1exMOnHnvjyYoA361qGqkvL-SCeCXC3wxWdRuAnzrQ130_provenance.